Progress on S-1 in the treatment of advanced breast cancer / 药学实践杂志

ABSTRACT

S-1 is the third generation of fluorouracil derivative anti-cancer agent with small side effects ,efficacy ,and drug delivery is convenient .In a large number of clinical trials and continuous clinical application ,it showed the good effect for the treatment of advanced breast cancer ,which was expected to become the first-line chemotherapy drug for breast cancer treat-ment in the future .